Home » USA Broker Ratings » Evolent Health, Inc – Consensus Indicates Potential 63.9% Upside

Evolent Health, Inc – Consensus Indicates Potential 63.9% Upside

Evolent Health, Inc found using ticker (EVH) now have 9 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 17 and 8 calculating the mean target price we have 11.67. With the stocks previous close at 7.12 this would indicate that there is a potential upside of 63.9%. The 50 day moving average now sits at 7.01 and the 200 moving average now moves to 7.83. The market cap for the company is $633m. You can visit the company’s website by visiting: http://www.evolenthealth.com

Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; delivery network alignments; and integrated cost and revenue management solutions. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Join us on our new LinkedIn page

Follow us on LinkedIn